Cryo-Cell International's revenue per share for the
three
months ended in Feb. 2024 was $0.95.
Cryo-Cell International's revenue per share for the trailing twelve months (TTM) ended in Feb. 2024 was $3.78.
Warning Sign:
Cryo-Cell International Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Cryo-Cell International was 3.60% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -0.60% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -1.40% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 8.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Cryo-Cell International's Revenue per Share or its related term are showing as below:
CCEL'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -18 Med: 9.9 Max: 97.8
Current: -0.6
During the past 13 years, Cryo-Cell International's highest 3-Year average Revenue Per Share Growth Rate was 97.80% per year. The lowest was -18.00% per year. And the median was 9.90% per year.
CCEL's 3-Year Revenue Growth Rate is ranked worse than 76.53% of 571
companies
in the Healthcare Providers & Services industry
Industry Median: 9.5
vs CCEL: -0.60
Cryo-Cell International Revenue per Share Historical Data
The historical data trend for Cryo-Cell International's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cryo-Cell International Annual Data
Trend
Nov14
Nov15
Nov16
Nov17
Nov18
Nov19
Nov20
Nov21
Nov22
Nov23
Revenue per Share
3.78
3.83
3.45
3.58
3.76
Cryo-Cell International Quarterly Data
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Aug22
Nov22
Feb23
May23
Aug23
Nov23
Feb24
Revenue per Share
0.93
0.93
0.94
0.95
0.95
Competitive Comparison
For the Medical Care Facilities subindustry, Cryo-Cell International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International PS Ratio Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's PS Ratio falls into.
Cryo-Cell International Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Cryo-Cell International's Revenue Per Share for the fiscal year that ended in Nov. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International (AMEX:CCEL) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Cryo-Cell International Revenue per Share Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your 